Palladyne AI Announces Commercial Availability of Palladyne IQ 2.0, Delivering Industrial Autonomy to Accelerate Defense-Industrial Modernization, Agility, a…

Palladyne AI (NASDAQ: PDYN) today announced the completion and commercial availability of Palladyne™ IQ 2.0. The Company’s ...

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...